Global Mesalamine Market Valued US$ 156.5 Million $ in 2027 - QYResearch Report

Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective. The industry's leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively. In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019. The global Mesalamine market size is projected to reach US$ 189.1 million by 2027, from US$ 156.5 million in 2020, at a CAGR of 3.2% during 2021-2027.

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/2792690/global-mesalamine-industry

In terms of production side, this report researches the Mesalamine production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type. In terms of consumption side, this report focuses on the consumption of Mesalamine by regions (countries) and by Application. The global Mesalamine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Mesalamine market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period. Geographic Segmentation The report offers exhaustive assessment of different region-wise Mesalamine markets such as North America, Europe, China and India, etc.

Key regions covered in the report are

U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Mesalamine market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume. Manufacturers The report includes comprehensive company profiling of leading and emerging companies competing in the global Mesalamine market. It provides a detailed list of players operating at a global level.

The players have been listed according to the type of products they offer in the global Mesalamine market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021. By Type and Application Segments The report includes a detailed analysis of leading and type and application segments of the global Mesalamine market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Mesalamine market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Mesalamine market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Mesalamine market by each application segment for the same period. This report includes the following manufacturers:, Syntese A/S, Divis Laboratories, Cambrex Corporation, Ipca Laboratories, Hangzhou Brother, PharmaZell, Lianyungang Fengheng Biopharm, Lasa Loboratory, Erregierre SpA, Corden Pharma Bergamo, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical

Market Segment by Type

, Purity ≥ 97%, Purity ≥ 98%, Purity ≥ 99%, According to the type, Mesalamine whose Purity ≥ 99% accounted for the largest global revenue share with 43.73% in 2019. Market Segment by Application, Mesalazine Tablets, Mesalazine Capsules, Others, Mesalazine Tablets took the largest market share in terms of volume, with 42.15% in 2019. Research Methodology To compile the detailed study of the global Mesalamine market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Mesalamine market. QY Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Mesalamine market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.

Request Customization of Report @ https://www.qyresearch.com/customize-request/form/2792690/global-mesalamine-industry

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Mesalamine Market Size Growth Rate by Type
1.2.2 Purity ≥ 97%
1.2.3 Purity ≥ 98%
1.2.4 Purity ≥ 99%
1.3 Market Segment by Application
1.3.1 Global Mesalamine Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Mesalazine Tablets
1.3.3 Mesalazine Capsules
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered 2 Market Perspective
2.1 Global Mesalamine Market Size (2016-2027)
2.1.1 Global Mesalamine Revenue (2016-2027)
2.1.2 Global Mesalamine Sales (2016-2027)
2.2 Global Mesalamine Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Mesalamine Sales by Regions (2016-2021)
2.2.2 Global Mesalamine Revenue by Regions (2016-2021)
2.3 Global Mesalamine Market Size Forecast by Region
2.3.1 Global Mesalamine Sales Forecast by Region (2022-2027)
2.3.2 Global Mesalamine Revenue Forecast by Region (2022-2027)
2.4 Global Top Mesalamine Regions (Countries) Ranking by Market Size
2.5 Mesalamine Industry Trends
2.5.1 Mesalamine Market Trends
2.5.2 Mesalamine Market Drivers
2.5.3 Mesalamine Market Challenges
2.5.4 Mesalamine Market Restraints 3 Competitive Landscape by Manufacturers
3.1 Global Top Mesalamine Manufacturers by Sales (2016-2021)
3.1.1 Global Mesalamine Sales by Manufacturers (2016-2021)
3.1.2 Global Mesalamine Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Mesalamine Sales in 2020
3.2 Global Top Manufacturers Mesalamine by Revenue
3.2.1 Global Mesalamine Revenue by Manufacturers (2016-2021)
3.2.2 Top Mesalamine Manufacturers Covered: Ranking by Revenue
3.2.3 Global Mesalamine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Mesalamine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mesalamine as of 2020)
3.4 Global Mesalamine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Mesalamine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Mesalamine Market
3.7 Key Manufacturers Mesalamine Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Mesalamine Market Size by Type
4.1 Global Mesalamine Historic Market Review by Type (2016-2021)
4.1.1 Global Mesalamine Sales Market Share by Type (2016-2021)
4.1.2 Global Mesalamine Revenue Market Share by Type (2016-2021)
4.1.3 Mesalamine Price by Type (2016-2021)
4.2 Global Mesalamine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Mesalamine Sales Forecast by Type (2022-2027)
4.2.2 Global Mesalamine Revenue Forecast by Type (2022-2027)
4.2.3 Mesalamine Price Forecast by Type (2022-2027) 5 Global Mesalamine Market Size by Application
5.1 Global Mesalamine Historic Market Review by Application (2016-2021)
5.1.2 Global Mesalamine Sales Market Share by Application (2016-2021)
5.1.3 Global Mesalamine Revenue Market Share by Application (2016-2021)
5.1.4 Mesalamine Price by Application (2016-2021)
5.2 Global Mesalamine Market Estimates and Forecasts by Application (2022-2027)
5.2.2 Global Mesalamine Sales Forecast by Application (2022-2027)
5.2.3 Global Mesalamine Revenue Forecast by Application (2022-2027)
5.2.4 Mesalamine Price Forecast by Application (2022-2027) 6 North America
6.1 North America Mesalamine Sales Breakdown by Company
6.1.1 North America Mesalamine Sales by Company (2016-2027)
6.1.2 North America Mesalamine Revenue by Company (2016-2027)
6.2 North America Mesalamine Market Size by Type (2016-2027)
6.2.1 North America Mesalamine Sales by Type (2016-2027)
6.2.2 North America Mesalamine Revenue by Type (2016-2027)
6.3 North America Mesalamine Market Size by Application (2016-2027)
6.3.1 North America Mesalamine Sales by Application (2016-2027)
6.3.2 North America Mesalamine Revenue by Application (2016-2027)
6.4 North America Mesalamine Market Size by Country
6.4.1 North America Mesalamine Sales by Country (2016-2027)
6.4.2 North America Mesalamine Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Mesalamine Sales Breakdown by Company
7.1.1 Europe Mesalamine Sales by Company (2016-2027)
7.1.2 Europe Mesalamine Revenue by Company (2016-2027)
7.2 Europe Mesalamine Market Size by Type (2016-2027)
7.2.1 Europe Mesalamine Sales by Type (2016-2027)
7.2.2 Europe Mesalamine Revenue by Type (2016-2027)
7.3 Europe Mesalamine Market Size by Application (2016-2027)
7.3.1 Europe Mesalamine Sales by Application (2016-2027)
7.3.2 Europe Mesalamine Revenue by Application (2016-2027)
7.4 Europe Mesalamine Market Size by Country
7.4.1 Europe Mesalamine Sales by Country (2016-2027)
7.4.2 Europe Mesalamine Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia 8 Asia Pacific
8.1 Asia Pacific Mesalamine Sales Breakdown by Company
8.1.1 Asia Pacific Mesalamine Sales by Company (2016-2027)
8.1.2 Asia Pacific Mesalamine Revenue by Company (2016-2027)
8.2 Asia Pacific Mesalamine Market Size by Type (2016-2027)
8.2.1 Asia Pacific Mesalamine Sales by Type (2016-2027)
8.2.2 Asia Pacific Mesalamine Revenue by Type (2016-2027)
8.3 Asia Pacific Mesalamine Market Size by Application (2016-2027)
8.3.1 Asia Pacific Mesalamine Sales by Application (2016-2027)
8.3.2 Asia Pacific Mesalamine Revenue by Application (2016-2027)
8.4 Asia Pacific Mesalamine Market Size by Regions
8.4.1 Asia Pacific Mesalamine Sales by Regions
8.4.2 Asia Pacific Mesalamine Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam 9 Latin America
9.1 Latin America Mesalamine Sales Breakdown by Company
9.1.1 Latin America Mesalamine Sales by Company (2016-2027)
9.1.2 Latin America Mesalamine Revenue by Company (2016-2027)
9.2 Latin America Mesalamine Market Size by Type (2016-2027)
9.2.1 Latin America Mesalamine Sales by Type (2016-2027)
9.2.2 Latin America Mesalamine Revenue by Type (2016-2027)
9.3 Latin America Mesalamine Market Size by Application (2016-2027)
9.3.1 Latin America Mesalamine Sales by Application (2016-2027)
9.3.2 Latin America Mesalamine Revenue by Application (2016-2027)
9.4 Latin America Mesalamine Market Size by Country
9.4.1 Latin America Mesalamine Sales by Country (2016-2027)
9.4.2 Latin America Mesalamine Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina 10 Middle East and Africa
10.1 Middle East and Africa Mesalamine Sales Breakdown by Company
10.1.1 Middle East and Africa Mesalamine Sales by Company (2016-2027)
10.1.2 Middle East and Africa Mesalamine Revenue by Company (2016-2027)
10.2 Middle East and Africa Mesalamine Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Mesalamine Sales by Type (2016-2027)
10.2.2 Middle East and Africa Mesalamine Revenue by Type (2016-2027)
10.3 Middle East and Africa Mesalamine Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Mesalamine Sales by Application (2016-2027)
10.3.2 Middle East and Africa Mesalamine Revenue by Application (2016-2027)
10.4 Middle East and Africa Mesalamine Market Size by Country
10.4.1 Middle East and Africa Mesalamine Sales by Country (2016-2027)
10.4.2 Middle East and Africa Mesalamine Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E 11 Company Profiles
11.1 Syntese A/S
11.1.1 Syntese A/S Corporation Information
11.1.2 Syntese A/S Overview
11.1.3 Syntese A/S Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Syntese A/S Mesalamine Products and Services
11.1.5 Syntese A/S Mesalamine SWOT Analysis
11.1.6 Syntese A/S Recent Developments
11.2 Divis Laboratories
11.2.1 Divis Laboratories Corporation Information
11.2.2 Divis Laboratories Overview
11.2.3 Divis Laboratories Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Divis Laboratories Mesalamine Products and Services
11.2.5 Divis Laboratories Mesalamine SWOT Analysis
11.2.6 Divis Laboratories Recent Developments
11.3 Cambrex Corporation
11.3.1 Cambrex Corporation Corporation Information
11.3.2 Cambrex Corporation Overview
11.3.3 Cambrex Corporation Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Cambrex Corporation Mesalamine Products and Services
11.3.5 Cambrex Corporation Mesalamine SWOT Analysis
11.3.6 Cambrex Corporation Recent Developments
11.4 Ipca Laboratories
11.4.1 Ipca Laboratories Corporation Information
11.4.2 Ipca Laboratories Overview
11.4.3 Ipca Laboratories Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Ipca Laboratories Mesalamine Products and Services
11.4.5 Ipca Laboratories Mesalamine SWOT Analysis
11.4.6 Ipca Laboratories Recent Developments
11.5 Hangzhou Brother
11.5.1 Hangzhou Brother Corporation Information
11.5.2 Hangzhou Brother Overview
11.5.3 Hangzhou Brother Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Hangzhou Brother Mesalamine Products and Services
11.5.5 Hangzhou Brother Mesalamine SWOT Analysis
11.5.6 Hangzhou Brother Recent Developments
11.6 PharmaZell
11.6.1 PharmaZell Corporation Information
11.6.2 PharmaZell Overview
11.6.3 PharmaZell Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 PharmaZell Mesalamine Products and Services
11.6.5 PharmaZell Mesalamine SWOT Analysis
11.6.6 PharmaZell Recent Developments
11.7 Lianyungang Fengheng Biopharm
11.7.1 Lianyungang Fengheng Biopharm Corporation Information
11.7.2 Lianyungang Fengheng Biopharm Overview
11.7.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Lianyungang Fengheng Biopharm Mesalamine Products and Services
11.7.5 Lianyungang Fengheng Biopharm Mesalamine SWOT Analysis
11.7.6 Lianyungang Fengheng Biopharm Recent Developments
11.8 Lasa Loboratory
11.8.1 Lasa Loboratory Corporation Information
11.8.2 Lasa Loboratory Overview
11.8.3 Lasa Loboratory Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Lasa Loboratory Mesalamine Products and Services
11.8.5 Lasa Loboratory Mesalamine SWOT Analysis
11.8.6 Lasa Loboratory Recent Developments
11.9 Erregierre SpA
11.9.1 Erregierre SpA Corporation Information
11.9.2 Erregierre SpA Overview
11.9.3 Erregierre SpA Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Erregierre SpA Mesalamine Products and Services
11.9.5 Erregierre SpA Mesalamine SWOT Analysis
11.9.6 Erregierre SpA Recent Developments
11.10 Corden Pharma Bergamo
11.10.1 Corden Pharma Bergamo Corporation Information
11.10.2 Corden Pharma Bergamo Overview
11.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Corden Pharma Bergamo Mesalamine Products and Services
11.10.5 Corden Pharma Bergamo Mesalamine SWOT Analysis
11.10.6 Corden Pharma Bergamo Recent Developments
11.11 CTX Lifescience
11.11.1 CTX Lifescience Corporation Information
11.11.2 CTX Lifescience Overview
11.11.3 CTX Lifescience Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 CTX Lifescience Mesalamine Products and Services
11.11.5 CTX Lifescience Recent Developments
11.12 Ishita Active Pharma Ingredients
11.12.1 Ishita Active Pharma Ingredients Corporation Information
11.12.2 Ishita Active Pharma Ingredients Overview
11.12.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Ishita Active Pharma Ingredients Mesalamine Products and Services
11.12.5 Ishita Active Pharma Ingredients Recent Developments
11.13 YC Biotech (Jiangsu)
11.13.1 YC Biotech (Jiangsu) Corporation Information
11.13.2 YC Biotech (Jiangsu) Overview
11.13.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 YC Biotech (Jiangsu) Mesalamine Products and Services
11.13.5 YC Biotech (Jiangsu) Recent Developments
11.14 Xinxiang Tianfeng Fine Chemical
11.14.1 Xinxiang Tianfeng Fine Chemical Corporation Information
11.14.2 Xinxiang Tianfeng Fine Chemical Overview
11.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Products and Services
11.14.5 Xinxiang Tianfeng Fine Chemical Recent Developments 12 Value Chain and Sales Channels Analysis
12.1 Mesalamine Value Chain Analysis
12.2 Mesalamine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mesalamine Production Mode & Process
12.4 Mesalamine Sales and Marketing
12.4.1 Mesalamine Sales Channels
12.4.2 Mesalamine Distributors
12.5 Mesalamine Customers 13 Research Findings and Conclusion 14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Why to Buy this Report?

Exhaustive analysis of business strategies of top players in the global Mesalamine market, the value chain, raw materials, and industry variables
Easy to understand, to-the-point data, statistics, and information on the global Mesalamine market, its segments, and sub-segments
Deep research on distribution channels and the distribution chain including retailers, wholesalers, manufacturers, dealers, suppliers, and consumers
Thorough evaluation of key regional Mesalamine markets based on CAGR, supply and demand, macroeconomic patterns, customer purchasing patterns, and several other factors
Accurate and comprehensive study of the global Mesalamine market with the help of SWOT analysis, PESTLE analysis, and opportunity assessment
The report is a perfect example of a detailed and meticulously prepared research study on the global Mesalamine market. It can be customized as per the requirements of the client. It not only caters to market players but also stakeholders and key decision makers looking for extensive research and analysis on the global Mesalamine market.

Get Full Report In Your Inbox Within 24 Hours at USD(5600): https://www.qyresearch.com/settlement/pre/94c55e22c78af5aa9432ad5a9dddcb53,0,1,global-mesalamine-industry

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

This release was published on openPR.